Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03118544 · ClinicalTrials.gov registry record
REduction of Contrast Via DyeVert Used in CTO Procedures
A clinical trial, sponsored by Minneapolis Heart Institute Foundation.
- Terminated
- Registry status
- 21
- Enrollment target
NCT03118544 is a clinical trial that was terminated before completion, run by Minneapolis Heart Institute Foundation. The registered enrollment target is 21 participants.
The verdict
NCT03118544 was terminated before completion, sponsored by Minneapolis Heart Institute Foundation.
- TERMINATED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The is an observational, prospective study to evaluate the effect of the DyeVert System on contrast volume administration in patients undergoing clinically-indicated chronic total occlusion (CTO) percutaneous coronary intervention (PCI)
Interventions
- DEVICE DyeVert System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-03-26 |
| Est. Completion | 2018-02-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03118544
The ClinicalTrials.gov registry entry for NCT03118544 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Minneapolis Heart Institute Foundation, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DyeVert System is the first listed.
NCT03118544 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03118544 about?
NCT03118544 is a clinical study titled "REduction of Contrast Via DyeVert Used in CTO Procedures". The is an observational, prospective study to evaluate the effect of the DyeVert System on contrast volume administration in patients undergoing clinically-indicated chronic total occlusion (CTO) percutaneous coronary intervention (PCI)
What is the current status of trial NCT03118544?
This trial is currently terminated. The enrollment target is 21 participants. The study started on 2017-03-26. Estimated completion is 2018-02-02.
What interventions are being tested in trial NCT03118544?
The interventions under investigation include: DyeVert System (DEVICE).
Who is sponsoring clinical trial NCT03118544?
This trial is sponsored by Minneapolis Heart Institute Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.